van Rensburg SJ, Hattingh C, Johannes C, Moremi KE, Peeters AV, van Heerden CJ, et al. Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases. Metab Brain Dis. 2021;36(6):1169-81.
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II
By Content Specialist|2022-06-06T10:46:05+02:00June 6, 2022|2021 Publication, 2021: July to September|Comments Off on Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection